Led by Dr David Rendle, the session covers real-world approaches to PPID (Cushing’s disease) and Equine Metabolic Syndrome (EMS), with a focus on improving long-term outcomes and addressing common challenges such as poor owner compliance with oral medications.
Originally developed for the Bova and Virbac Equine Roadshow, this webinar explores equine behaviour modification, focusing on how learned behaviours develop and how to effectively manage them in practice. It covers identifying key triggers, understanding the role of conditioning, and applying reinforcement strategies to support positive behavioural change.
Originally developed for the Bova and Virbac Equine Roadshow, this webinar explores the complex intersection between behaviour and discomfort, challenging clinicians to ask: is this truly a behavioural issue, or a horse in pain?
Originally developed for the Bova and Virbac Equine Roadshow 2026, in Australia, this session sees Dr David Rendle explore the latest insights into equine gastric disease, with a focus on the differences between squamous (ESGD) and glandular (EGGD) disease.
This session provides a concise, evidence-based update on canine haemangiosarcoma, with a strong focus on contemporary treatment strategies. It includes a brief, targeted review of current literature outlining standard-of-care approaches, outcomes, and the limitations of existing therapies.
Anthelmintic resistance is a growing threat to equine welfare, and vets play a key role in driving the behaviour changes needed. This talk reviews the latest evidence and expert consensus on sustainable equine parasite control, highlighting updated risk-based approaches from the BEVA ProtectMeToo Toolkit and CANTER Guidelines. Attendees will leave informed, motivated, and ready to champion responsible deworming – protecting equine health, welfare, and the environment.
In this free webinar, Margie will share practical, real-world approaches to common anaesthetic and analgesic challenges, with a focus on what can be achieved, even when working with limited agents, drugs, or resources in unique clinical settings.
Discover new therapeutic approaches for Feline Chronic Gingivostomatitis, including EIDD-1931, doxycycline, and meloxicam. Join Dr Andrea Harvey.
